Pisciotta A V, Cronkite C, Hanson G A, Brodsky J B, Donovan P B, Wasserman L R
J Lab Clin Med. 1983 Mar;101(3):432-40.
Studies were made to test immune reactivity between anti-leukemic cell sera and nonadherent peripheral blood cells from patients with leukemic and nonleukemic P. vera. Cells from seven patients with leukemic P. vera had complement-dependent cytotoxicity test results showing more than 80% cell killing. In comparison, leukocytes from 37 nonleukemic and nonpolycythemic subjects, with and without blood disorders, failed to show significant cytotoxicity. Cells from 20 patients with nonleukemic P. vera and 10 patients with myelofibrosis, thrombocythemia, and "spent" P. vera also failed to react. Three nonleukemic P. vera patients showed a positive reaction that became progressively stronger; they developed leukemia at a later date. The association of positive reactivity before leukemia is overt, to later development of acute leukemia calls attention to the possible use of immunologic technology as a means of early diagnosis of leukemia.
开展了多项研究,以检测抗白血病细胞血清与真性红细胞增多症白血病患者和非白血病患者的非黏附外周血细胞之间的免疫反应性。7例真性红细胞增多症白血病患者的细胞进行补体依赖性细胞毒性试验,结果显示细胞杀伤率超过80%。相比之下,37例非白血病且非红细胞增多症患者的白细胞,无论有无血液疾病,均未显示出明显的细胞毒性。20例非白血病真性红细胞增多症患者以及10例骨髓纤维化、血小板增多症和“耗竭型”真性红细胞增多症患者的细胞也未出现反应。3例非白血病真性红细胞增多症患者呈阳性反应,且反应逐渐增强;他们后来患上了白血病。白血病明显发作前的阳性反应与随后急性白血病的发生之间的关联,促使人们关注免疫技术作为白血病早期诊断手段的可能用途。